Back to search

United States· US:72603-113_258be954-8e31-2be4-e063-6394a90a78ca

Clorazepate Dipotassium

A medicinal product containing clorazepate dipotassium, registered in United States by NORTHSTAR RX LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedClorazepate DipotassiumATC—REGISTER NO.US:72603-113_258be954…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CLORAZEPATE DIPOTASSIUM
Manufacturer
NORTHSTAR RX LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    7260311301
    100 TABLET in 1 BOTTLE (72603-113-01)
  • ndc11
    7260311302
    500 TABLET in 1 BOTTLE (72603-113-02)
  • ndc11
    72603-113-01
  • ndc11
    72603-113-02

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Clorazepate dipotassium in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clorazepate dipotassium products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Tranxene, Uni-Tranxene
  • Germany · Tranxilium, Tranxilium Tabs
  • Spain · Clorazepato Normon, Tranxilium
  • France · Tranxene
  • Greece · Tranxene
  • Italy · Transene
  • Lithuania · Tranxene
  • Luxembourg · Tranxene, Uni-Tranxene
  • Netherlands · Tranxène, Tranxène Mb
  • Poland · Cloranxen, Tranxene
  • Portugal · Medipax, Tranxene

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6845e95-d7f5-4798-8481-5ea150ef2b3b
GET /v1/drugs/c6845e95-d7f5-4798-8481-5ea150ef2b3b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "7.5",
  "substance": "CLORAZEPATE DIPOTASSIUM",
  "productndc": "72603-113",
  "dosage_form": "TABLET",
  "dea_schedule": "CIV",
  "strength_unit": "mg/1",
  "application_number": "ANDA075731",
  "marketing_category": "ANDA"
}

See everything about clorazepate dipotassium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.